$385 Million is the total value of COMPTON CAPITAL MANAGEMENT INC /RI's 161 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GSAT | Exit | GLOBALSTAR INC | $0 | – | -15,000 | -100.0% | -0.01% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -715 | -100.0% | -0.06% | – |
| CHWY | Exit | CHEWY INC - CLASS Acl a | $0 | – | -2,940 | -100.0% | -0.06% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -2,200 | -100.0% | -0.06% | – |
| EEM | Exit | ISHARES MSCI EMERGING MKTS ETFmsci emg mkt etf | $0 | – | -5,225 | -100.0% | -0.08% | – |
| DKNG | Exit | DRAFTKINGS INC - CL A | $0 | – | -14,420 | -100.0% | -0.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC | 41 | Q2 2023 | 48.1% |
| CISCO SYSTEMS INC | 41 | Q2 2023 | 10.0% |
| JP MORGAN CHASE & CO | 41 | Q2 2023 | 4.7% |
| MICROSOFT CORP | 41 | Q2 2023 | 4.8% |
| ABBOTT LABORATORIES | 41 | Q2 2023 | 5.2% |
| NIKE INC-B | 40 | Q1 2023 | 3.4% |
| GILEAD SCIENCES INC | 40 | Q1 2023 | 4.5% |
| LOWES COS INC | 40 | Q1 2023 | 4.0% |
| THERMO FISHER SCIENTIFIC INC | 40 | Q1 2023 | 3.0% |
| VERIZON COMMUNICATIONS INC | 40 | Q1 2023 | 2.3% |
View COMPTON CAPITAL MANAGEMENT INC /RI's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-08 |
| 13F-HR/A | 2022-08-11 |
| 13F-HR | 2022-08-04 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-07 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-08-11 |
View COMPTON CAPITAL MANAGEMENT INC /RI's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.